bluebird bio Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : bluebird bio Inc.

BLUE 4.970

0.0%

Jun 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biotech Jim who wrote (38)	1/9/2014 2:13:27 PM
From: tuck	Read Replies (1) of 163

It's been noted that there were almost 17 million shares available for sale upon lockup expiration (which was about a month ago), compared to the 6 million then on the market. Most folks here seem excited by the CAR T technology, but these programs are so early, and it seems as though a good deal of hype on those programs has already passed recently (Celgene deal, ASH). Do you or others following more closely know when the upcoming inflection points are? I imagine they are more likely to be associated with the gene therapy programs. And have we heard anything about their burn rate? They seem to own their later stage programs, which normally means big expenses, but the U.S. trials in these indications with small populations don't enroll many folks, so maybe clinical expenses aren't a big concern. Watching and waiting for better entry pending above info. TIA & Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next